NxStage Voluntary Sak Recall
Higher levels of endotoxin than NxStage tolerates were found in less than 1% of affected sak lots, so they notified patients who had those lots and issued a voluntary recall. An FDA recall was not required.
Read the full article » | Posted 02-15-2018
- Dialyze Direct Expands Posted 01-14-2022
- Fresenius Provides China with New Options to Dialyze at Home Posted 12-16-2021
- Baxter Launches My Kidney Journey in the Asian Pacific Region Posted 12-16-2021
- FMC Named Among Newsweek Magazine’s “Most Loved Workplaces” Posted 11-12-2021